LyGenesis, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.lygenesis.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes
Phase 2
Recruiting
- Conditions
- End Stage Liver Disease
- First Posted Date
- 2020-08-03
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- LyGenesis, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04496479
- Locations
- 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States
🇺🇸Houston Methodist Hospital, Houston, Texas, United States
News
No news found